Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangdong Marubi Biotechnology Co PB Ratio?
Guangdong Marubi Biotechnology CoSHSE:603983 +2.14%71 PB Ratio is 3.35 as of Jul. 31, 2026, which is 21% below its 10-year median of 4.24. GuruFocus rates SHSE:603983 with a GF Score™ of 71/100 and a GF Value™ of ¥45.12 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,897 Consumer Packaged Goods companies, Guangdong Marubi Biotechnology Co ranks worse than 82.76% on this metric.
SHSE:603983'
s PB Ratio Range Over the Past 10 Years
Min: 2.55 Med: 4.24 Max: 13.7
Current: 3.35
During the past 13 years, Guangdong Marubi Biotechnology Co's highest PB Ratio was 13.70. The lowest was 2.55. And the median was 4.24.
SHSE:603983's PB Ratio is ranked worse than 82.76% of 1897
companies
in the Consumer Packaged Goods industry
Industry Median: 1.36
vs SHSE:603983: 3.35
During the past 12 months, Guangdong Marubi Biotechnology Co's average Book Value Per Share Growth Rate was -2.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 17.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Guangdong Marubi Biotechnology Co was 42.50% per year. The lowest was -30.10% per year. And the median was 5.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Guangdong Marubi Biotechnology Co PB Ratio Related Terms
Guangdong Marubi Biotechnology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Marubi Biotechnology Co PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Guangdong Marubi Biotechnology Co's PB Ratio falls into.
Guangdong Marubi Biotechnology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Guangdong Marubi Biotechnology Co (SHSE:603983) has a PB Ratio of 3.35 as of Jul. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangdong Marubi Biotechnology Co and its competitors. This is 21% below median its historical median of 4.24. Over the past decade, Guangdong Marubi Biotechnology Co's PB Ratio has ranged from 2.55 to 13.70. According to the industry distribution chart, Guangdong Marubi Biotechnology Co ranks #1570 out of 1897 companies in the Consumer Packaged Goods industry, placing it in the top 82.8%.
Is Guangdong Marubi Biotechnology Co's PB Ratio too high?
Guangdong Marubi Biotechnology Co's current PB Ratio of 3.35 is 21% below median its 10-year median of 4.24. Over the past 10 years, this metric has ranged from a low of 2.55 to a high of 13.70. The Consumer Packaged Goods industry median PB Ratio is 1.36. Guangdong Marubi Biotechnology Co's value of 3.35 is 146.3% above this industry median. Based on the distribution chart, Guangdong Marubi Biotechnology Co ranks #1570 out of 1897 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's PB Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Marubi Biotechnology Co ranks #1570 out of 1897 companies for PB Ratio. This places Guangdong Marubi Biotechnology Co in the lower half of its industry. The industry median PB Ratio is 1.36. Guangdong Marubi Biotechnology Co's value of 3.35 is 146.3% above this benchmark. Historically, Guangdong Marubi Biotechnology Co's own PB Ratio has ranged from 2.55 to 13.70 over the past decade. While the company's 10-year median is 4.24 vs. the industry median of 1.36, Guangdong Marubi Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,897 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Marubi Biotechnology Co's current PB Ratio of 3.35 is 146.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangdong Marubi Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Marubi Biotechnology Co's current PB Ratio is 3.35, which is 21% below median its own 10-year median of 4.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥45.12, compared to a current price of ¥28.67 — trading 36.5% below its estimated fair value. The current PB Ratio is 3.35, which is 21% below median its 10-year median of 4.24 and 146.3% above the Consumer Packaged Goods industry median of 1.36. Guangdong Marubi Biotechnology Co's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current PB Ratio is 3.35 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued.
The current stock price of ¥28.67 is trading 36.5% below its estimated GF Value™ of ¥45.12.
GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.
Key valuation signals for SHSE:603983:
PB Ratio: 3.35 (21% below median its 10-year median of 4.24)
GF Value™: ¥45.12 vs. price of ¥28.67 (36.5% below fair value)
Industry Position: 146.3% above the Consumer Packaged Goods median (#1570 of 1897)
No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603983 has been successfully added to your 
